Friday, June 26, 2020 Daily Archives

Early Stage Analytical Considerations for Late Stage Biologics Success

by

This BPI Special Report will cover phase appropriate analytical strategies that will balance various drivers to meet overall development goals without sacrificing the requirements of a program. The goal is to provide important recommendations for analytical method development that can help the biopharmaceutical industry identify opportunities to improve lead time and reduce development costs while maintaining required quality standards. Fill out the form below to learn more about analytical method development now.   Arugadoss Devakumar, PhD, is director of analytical…

June 26, 2020

Moderna times: Catalent captures another COVID contract

by

Catalent has announced it will support a third ‘Operation Warp Speed’ COVID-19 candidate by providing commercial fill/finish for Moderna Therapeutics’ mRNA vaccine. The deal announced this week will see contract development and manufacturing organization (CDMO) Catalent provide vial filling and packaging capacity from its facility in Bloomington, Indiana for Moderna Therapeutics’ vaccine candidate mRNA-1273. “Moderna will leverage the site’s existing filling lines and recent packaging expansion, which provides fully automated and high-speed packaging capabilities to accelerate manufacturing timelines,†a Catalent…

June 26, 2020